Telemental health company Brightside Health announced it raised $33 million dollars in Series C funding powered by healthcare-focused venture capital firm S32.
Kennedy Lewis, Time BioVentures, and 23andMe founder Anne Wojcicki participated in the round. Existing investors ACME, Mousse Partners and TriVentures also contributed.
The company confirmed the $33 million raise in an email to...
Life sciences software company Synthace has raised $35 million (€30.6M) in Series C funding to expand the reach of its research and development (R&D) cloud platform, where scientists can record and share their research and insights.
The R&D-focused, no-code software platform enables scientists to share, view and access progress with cures and therapeutics in one place, making it simpler...
Ophthalmic startup EyeYon Medical announced today the completion of a $25 million in a Series C funding.
The round was led by CR-CP Life Science Fund, which invests in life science companies that develop drugs, cell therapies, medical devices, and smart healthcare technology.
Other participants in the round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and...
Indonesia-based healthcare superapp Alodokter announced that it has raised a $33M Series C funding led by Sequis Life and with participation from Philips, Heritas Capital, Hera Capital, Dayli Partners and others. Existing investors Softbank Ventures Asia and Golden Gate Ventures also participated in the round. The startup was founded in 2014 by Suci Arumsari (Co-founder & Director Alodokter...
Shanghai-based medical AI startup Synyi announced that it has raised RMB 250M ($36.3M) in Series C funding led by Chinese tech giant Tencent. Founded in 2016, Synyi started with Natural Language Processing (NLP) capabilities in the Chinese language and focused on hospitals’ demand for scientific research data, combining AI & HIT to create their first smart analytics platform.
To solve the...
